AzTrials
AzTrials

Young AdultsCUPCAKENCT05188755

Fitness Assessment in Young Adults Recovered From Lymphoma

A study testing Indirect calorimetric test during submaximal exercise in people with Young Adults and Lymphoma, Non-Hodgkin, run by University Hospital, Clermont-Ferrand at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Regular physical activity (PA) is associated with maintaining body composition, increased cardiorespiratory capacity, muscle mass and bone mineral density. In the event of a cancer, the development of physical capacities and metabolism may therefore be disturbed by cancer, these associated treatments (chemotherapy… Read more about this study

Who is it for?
Ages 18 to 25 yearsHealthy volunteers can take part
What is being tested?
Indirect calorimetric test during submaximal exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
44 participants
Where
1 siteFrance
Study dates
1 Jan 2022to 6 Dec 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 25 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Young adult male or female, aged 18 to 25
  • giving free and informed consent
  • Hodgkin lymphoma or non-Hodgkin lymphoma in the healing stage
  • Cured (defined by an undetectable disease at the end of treatment) for at least one year and maximum 6 years of lymphoma or Hodgkin's disease

Who cannot join

  • Legal incapable adults
  • People under judicial protection
  • Treatment with systemic glucocorticoids for more than a week, during the 30 days preceding the tests
  • Medical contraindication to the practice of physical exercise
  • Any pathologies (other than the history of lymphoma for the cases) likely to affect the metabolism or the muscle mass
  • Any treatment that may have an influence on the energy metabolism
Show all 9Show fewer
  • Active infection
  • Pregnant, breastfeeding, or likely to be
  • Subject's refusal to participate

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHU de Clermont-Ferrand

    Clermont-Ferrand, 63000

Other trials in France

About this study

Official title: Fitness Assessment in Young Adults Recovered From Lymphoma or Hodgkin's Disease

Regular physical activity (PA) is associated with maintaining body composition, increased cardiorespiratory capacity, muscle mass and bone mineral density. In the event of a cancer, the development of physical capacities and metabolism may therefore be disturbed by cancer, these associated treatments (chemotherapy, radiotherapy and hematopoietic stem cell transplantation) but also undernutrition and the reduction in physical activity or even a sedentary lifestyle.

Although the benefits of PA in oncology are now well identified for adult populations, studies are still rare in the population of children, adolescents and young adults, and the results are still difficult to generalize. As a result, there is no recommendation on the practice of physical activity in pediatric oncology or adolescents and young adults and the levels of physical activity of cured patients remain lower than those of the general population.

Read more

Fitness is a marker of health in adults as well as in adolescents. Physical condition is a set of components such as cardiorespiratory capacity (transport and use of O2), body composition (distribution of bone, muscle and fat masses) and muscle function (strength, power, fatigue, energy metabolism) .

The investigators hypothesize that, compared to young adults, recovered from lymphoma are expected to exhibit impaired physical condition, due to physical deconditioning.

Being tested
Indirect calorimetric test during submaximal exercise
Keywords
physical fitness, fat oxidation, metabolism, exercise
Medical subject headings
Lymphoma, Non-Hodgkin, Hodgkin Disease, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Indirect calorimetric test during submaximal exerciseOther

    Also called cardiac output, body composition, assessment of physical capacity, blood test

    • metabolic evaluation by indirect calorimetry at rest and during exercise
    • evaluation of cardiac output
    • peripheral quantitative computed tomography (pQCT) of the muscle cross section
    • evaluation of body composition
    • assessment of physical capacity (chair test and 3 min step-test)
    • blood test
    • assess the level of physical activity
Study groups in NCT05188755
Study groupRoleWhat they receive
Healthy controlsActive comparatorsex and age matched healthy controls
Receives: Other: Indirect calorimetric test during submaximal exercise
young adults recovered from lymphoma or Hodgkin's diseaseExperimentalyoung adults recovered from lymphoma or Hodgkin's disease
Receives: Other: Indirect calorimetric test during submaximal exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. fat oxidation rate

    maximum rate of lipid oxidation (in mg/ml)

    Measured: day at 11:30 am during one day

Secondary outcomes (14)
  1. rest metabolism

    energy expenditure at rest in kcal.

    Measured: at 08:00 am in fasted condition during one day

  2. blood insulinemia

    blood value of insulin in pmol/L

    Measured: at 07:30 am in fasted condition during one day

  3. blood N-terminal pro-B natriuretic peptide

    blood N-terminal pro-B natriuretic peptide level in g/L

    Measured: at 07:30 am in fasted condition during one day

  4. blood troponin

    blood troponin level in g/L

    Measured: at 07:30 am in fasted condition during one day

  5. blood lipids

    blood lipids level in g/L

    Measured: at 07:30 am in fasted condition during one day

  6. blood glucose

    blood glucose level in g/L

    Measured: at 07:30 am in fasted condition during one day

  7. Body composition: fat

    percentage of fat

    Measured: at 07:30 am during one day

  8. Body composition: lean mass

    percentage of lean mass

    Measured: at 07:30 am during one day

  9. cardiac output

    Systolic Ejection Volume in mL evaluated at rest and during submaximal exercise

    Measured: at 11:30 am during one day

  10. peripheral quantitative computed tomography

    Cross-sectional area of thigh muscles and intermuscular adipose tissue were assessed for muscle at 40% of the length between the greater trochanter and the mid-patella of the right leg

    Measured: at 10:45 am during one day

  11. physical condition

    3 min step-test (number of ascent / descent step)

    Measured: at 08:45 am during one day

  12. physical capacity

    chair test (time in second held in position)

    Measured: at 08:45 am during one day

  13. physical activity level

    daily energy expenditure (in Kcal)

    Measured: from day 2 to day 5

  14. sedentary level

    total sedentary time (in min) evaluated by accelerometer for 4 days

    Measured: from day 2 to day 5

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jan 2022
  2. Study start1 Jan 2022
  3. Primary completion6 Dec 2022
  4. Study completion6 Dec 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
group 1: healthy controls group 2 : young adults recovered from lymphoma or Hodgkin's disease
Masking
None (open label)
Enrolment
44 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05188755
Sponsor's protocol ID
RBHP 2021 KANOLD
Other IDs
2021-A02184-37
Acronym
CUPCAKE
Status last verified
Nov 2021
First submitted
29 Nov 2021
Last updated
23 Dec 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Indirect calorimetric test during submaximal exercise in people with Young Adults and Lymphoma, Non-Hodgkin, run by University Hospital, Clermont-Ferrand at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

fat oxidation rate (time frame: day at 11:30 am during one day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Dec 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in